The use of metformin in the treatment of Intrahepatic cholestasis of pregnancy
KeywordsIntrahepatic cholestasis of pregnancy, metformin, lipid disorders, ICP
Introduction: Intrahepatic cholestasis of pregnancy (ICP) is the most common pregnancy-related liver disease. It is characterized by persistent pruritus, usually occurring after 30 weeks of pregnancy, and by elevated levels of bile acids and transaminases, which decrease over the course of 2-3 weeks postpartum. [1,2]The occurrence of ICP in the mother may be associated with significant complications in the fetus, such as: preterm labor, intrauterine asphyxia, or sudden fetal death. Currently, the treatment of choice is ursodeoxycholic acid (UDCA).[2,6] Recently, it was observed that the administration of metformin in cases not responding to standard therapy improved lipid disorders in pregnant women.
The aim of the study: The aim of the study is to present the possibility of using metformin in the treatment of ICP in pregnant women not responding to standard treatment and to present a clinical case..
Material and methods: The work is a review of the literature on the management of ICP and the use of metformin in the treatment of lipid metabolism disorders, as well as a brief case report of a patient with intrahepatic cholestasis of pregnancy.
Description of the state of knowledge: Metformin is an oral antidiabetic drug belonging to the group of biguanides. However, the latest observations show that metformin also has a beneficial effect on the liver function and on the lipid metabolism in pregnant women. In these patients, the levels of bile acids and liver enzymes decreased after the use of metformin.
Summary: The mechanism of action of metformin explaining its beneficial effect on the lipid metabolism in pregnant women with intrahepatic cholestasis is not fully understood.
Milkiewicz P., Elias E., Williamson C., Weaver J. Obstetric cholestasis. BMJ 2002; 324: 123–124.
Lammert F., Marschall H.U., Glantz A., Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diag- nosis and management. J. Hepatol. 2000; 33: 1012–1021.
Lee R.H., Goodwin T.M., Greenspoon J., Incerpi M. The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J. Perinatol. 2006; 26: 527–532.
Metformina – mechanizmy działania i zastosowanie w terapii cukrzycy typu 2 , Marzena Grzybowska, Joanna Bober, Maria Olszewska
Metformina w ciąży , Polskie Towarzystwo Ginekologiczne, Julia Bijok, Małgorzata Bińkowska, Grzegorz Jakiel
Rekomendacje Zespołu Ekspertów Polskiego Towarzystwa Ginekologicznego dotyczące postępowania w wewnątrzwątrobowej cholestazie ciężarnych , prof.dr hab.Bożena Leszczyńska-Gorzelak, prof. dr hab.Jan Oleszczuk , dr Beata Marciniak, prof. dr hab.Ryszard Poręba, prof. dr hab.Przemysław Oszukowski, prof.dr hab.Mirosław Wielgoś , prof. dr hab.Krzysztof Czajkowski.
How to Cite
Copyright (c) 2022 Paulina Pawłowska, Justyna Wójcik-Grudzień, Alicja Ozga, Martyna Rozenbajgier
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Number of views and downloads: 273
Number of citations: 0